Abstract
Historically, treatment of acute type B aortic dissection (TBAD) has been primarily medical management via impulse control, with intervention reserved for complicated presentations. At present, early usage of thoracic endovascular aortic repair (TEVAR) has been increasing to treat TBAD. The primary aim of the present study was to evaluate readmissions and treatment failure of TEVAR vs medical management alone as the initial treatment strategy for acute uncomplicated TBAD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
